Speech-Language Pathologists in Evesham, NJ Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Kathleen Mullee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 751 Route 73 N Ste 1, Evesham, NJ 08053 Phone: 856-375-2914 |
Annelie Fernanda Simuro Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 108 Centre Blvd, Evesham, NJ 08053 Phone: 732-833-3723 |
News Archive
S45F mutation may offer identifiable risk factor in recurrent pediatric aggressive fibromatosis
In the case of aggressive fibromatosis, the good news is that it is a slow-growing benign tumor. The bad news is that this abdominal tumor often recurs after surgical removal. This is particularly true among children. While headway has been made in isolating causes of this recurrence in adults, it is less clear in children.
University of Birmingham researchers receive £1.5 million to find new treatments for bowel cancer
Charity Cancer Research UK has awarded the University of Birmingham £1.5 million to fund a five-year research program aimed at finding new treatments for bowel cancer.
PSR launches OrphanIQ website for companies involved in Orphan Drug development
PSR announced today the launch of its new service and dedicated website, OrphanIQ. OrphanIQ is a quick and easy way for companies involved in Orphan Drug development to ask a short question on a variety of topics without the need for setting up time-consuming agreements and contracts. Questions will be handled by the relevant expert, who will first assess whether the question can be answered without obtaining further information, and within a reasonable time-frame, and will subsequently provide a written answer.
Diabetes prevalence highest in the Southern and Appalachian states
Diabetes prevalence is highest in the Southern and Appalachian states and lowest in the Midwest and the Northeast of America. Researchers writing in BioMed Central's open access journal Population Health Metrics have used two public data sources to investigate the prevalence of diagnosed and undiagnosed diabetes mellitus at the State level.
FDA approves first cranial dural sealant
Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.
› Verified 7 days ago